Order Article Reprints

Zhuo L, Ma M, Zhang J, Zhou J, Zheng Y, Liang A, Sun Q, Liu J, Liao W. Qifu Decoction Alleviates Lipopolysaccharide-Induced Myocardial Dysfunction by Inhibiting TLR4/NF-κB/NLRP3 Inflammatory Pathway and Activating PPARα/CPT Pathway. Pharmaceuticals. 2025; 18(8):1109. https://doi.org/10.3390/ph18081109

Zhuo, Lingxin, Mingxuan Ma, Jiayi Zhang, Jiayu Zhou, Yuqi Zheng, Aiyin Liang, Qingqing Sun, Jia Liu, and Wenting Liao. 2025. "Qifu Decoction Alleviates Lipopolysaccharide-Induced Myocardial Dysfunction by Inhibiting TLR4/NF-κB/NLRP3 Inflammatory Pathway and Activating PPARα/CPT Pathway" Pharmaceuticals 18, no. 8: 1109. https://doi.org/10.3390/ph18081109

Zhuo, L., Ma, M., Zhang, J., Zhou, J., Zheng, Y., Liang, A., Sun, Q., Liu, J., & Liao, W. (2025). Qifu Decoction Alleviates Lipopolysaccharide-Induced Myocardial Dysfunction by Inhibiting TLR4/NF-κB/NLRP3 Inflammatory Pathway and Activating PPARα/CPT Pathway. Pharmaceuticals, 18(8), 1109. https://doi.org/10.3390/ph18081109